Suspected chromium picolinate-induced rhabdomyolysis

Pharmacotherapy

Volumn 18, Issue 4, 1998, Pages 860-862

  Martin, William R ^a   Fuller, Robert E ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM PICOLINATE; HYPOCHOLESTEROLEMIC AGENT; MEVINOLIN;

ADULT; ARTICLE; BODY BUILDING; CASE REPORT; CLINICAL FEATURE; DIET SUPPLEMENTATION; FEMALE; HUMAN; MUSCLE INJURY; RHABDOMYOLYSIS;

ADULT; HUMANS; IRON CHELATING AGENTS; OVERDOSE; PICOLINIC ACIDS; RHABDOMYOLYSIS;

EID: 0031854790     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Fuentes RJ, Rosenberg JM, Davis A, eds. Athletic drug reference '93. Durham, NC: Clean Data, 1993.
2. Food and Nutrition Board, National Research Council. Recommenced dietary allowances, 10th ed. Washington, DC: National Academy of Sciences, 1989.
3. Gabow PA, Kaehny WD, Kellher SP. The spectrum of rhabdomyolysis. Medicine 1982;61:141-52.
4. Reha WC, Mangano FA, Zeman RK, Pahira JJ. Rhabdomyolysis: need for high index of suspicion. Urology 1989;34:292-6.
5. Arrington ED, Miller MD. Skeletal muscle injuries. Orthop Clin North Am 1995;26:411-22.
6. Sinert R, Kohl L, Rainone T, Scalea T. Exercise-induced rhabdomyolysis. Ann Emerg Med 1994;23:1301-6.
7. Bolgiano EB. Acute rhabdomyolysis due to body building exercise. J Sports Med Phys Fitness 1994;34:76-8.
8. Knochel JP. Rhabdomyolysis and myoglobinuria. Semin Nephrol 1981;1:75-86.
9. Kakulas BA. Experimental myopathies. In: Walton SJ, ed. Disorders of voluntary muscle. New York: Churchill Livingstone, 1981:393-400.
10. London SF, Gross KF, Ringel SP. Cholesterol-lowering agent myopathy (CLAM). Neurology 1991;41:1159-60.
11. Wallace CS, Mueller BA. Lovastatin-induced rhabdomyolysis in the absence of concomitant drugs. Ann Pharmacother 1992;26:190-2.